HOW YOUR BODY KILLS VIRUSES
In this special report, we will look at how your body kills viruses that enter it, and the limited potency and effect of drugs. Viruses gain entry into the body through - the nose (the virus is carried in dust / pollen/ spray from a sneeze); through the mouth (food, drinks that are contaminated), through the blood (transfusion, cuts and breaks in the skin) and through sexual organs/ fluids.
A virus's worst enemy is the human immune system. When an unknown pathogen like the new coronavirus invades, the body naturally develops antibodies that can seek out and destroy the interloper. (Time Magazine, Apr. 28, 2003)
Your body has an immune system, which you can liken to your Ministry of Defence. Of the
many immune cells - "NK cells", "B cells", "T cells", "anti-bodies", "interferon" etc. all have a function in KEEPING YOU HEALTHY, WHEN THE VIRUS HAS GAINED ENTRY INTO YOUR BODY, EVEN WHEN PEOPLE AROUND YOU ARE SICK. Think of the times when someone in the office has the flu and others don't. The difference is the "fire power" of your immune system, and its IDENTIFICATION SYSTEM - TO RECOGNISE AND KILL FOREIGN MATTERS IN YOUR BODY.
"WHO" MONITORS VIRAL INVASIONS?
At the heart of the immune response is the ability to distinguish between self and nonself. Every body cell carries distinctive molecules that distinguish it as "self." Normally the body's defenses do not attack tissues that carry a self marker; rather, immune cells coexist peaceably with other body cells in a state known as self-tolerance. When a virus has inflitrated a cell, it changes some marker, and the ideally the immune cells then recognise this sick cell as "non-self:.
WHAT ABOUT DRUGS THAT KILL VIRUSES?
Viruses are parasites incapable of reproducing on their own. They're inactive—that is, until they burrow into a host cell, taking over its functions in order to replicate and thereby destroying the host. Inside the body, they become vulnerable to drugs only after they invade a cell, but any treatment may damage the cell as well. And even when scientists develop an effective vaccine or antiviral agent, viruses can suddenly mutate—potentially becoming deadlier and even tougher to eliminate.
HOW DOES THE BODY'S IMMUNE SYSTEM REACT?
Your "NK cells" - which stands for NATURAL KILLER CELLS (this is the proper name for it, as used in the scientific and medical circles and in general usage). The NK cells targets "non-self", i.e. cells that ar not an integral part of you (or your "self"). NK cells are part of your body's innate immune response, and is in the first line of defence.
The innate immune response is characterized by the fact that it does not require prior exposure to an infectious agent.
HOW DO NK CELLS KILL?
NK Cells contain granules filled with potent chemicals, and kill on contact. The killer binds to its target, aims its weapons, and delivers a burst of lethal chemicals.
When a virus attacks a cell, it penetrates the cell and injects its viral DNA into your cell, uses your cell to help it reproduce, and spread itself. (that is why computer viruses are named as such).
Well, your NK cells search and destroy these infected cells. In other words if the infected cells can be stopped early enough, it is prevented from spreading in your body. Remember it spreads alarmingly quickly - geometric progression - ie. 2 to 4, to 8,16, 32, 64 etc. in several minutes. It can grow to millions in a short time - in a matter of several hours and days.
 |
| NK Cells contain granules filled with potent chemicals, and kill on contact. The killer binds to its target, aims its weapons, and delivers a burst of lethal chemicals. |
WHAT IS THE DIFFERENCE NK CELLS ACTIVITY COMPARED WITH DRUGS?
NK cell targets specifically, all "non-self" cells without prior exposure to the infectious agent. In other words the are pre-armed, fore-warned, unlike drugs.
NK CELL AND CANCER
The NK cells are the first line of defence in your body. What else does the NK cell do? It also monitors and seek out and destroy other non-self cells - including CANCER CELLS.
 |
When normal cells turn into cancer cells, through mutation, or DNA damage, some of the antigens on their surface change.
These new or altered antigens flag immune defenders, including cytotoxic T cells, natural killer cells, and macrophages. |
WHAT CAN WE DO TO BOOST NK CELL ACTIVITY IN OUR BODY?
WOULD CERTAIN HEALTH SUPPLEMENTS HELP?
That is a good question. Prominent scientists and medical researchers in the USA had conducted a 6 year study recently (late 90s) to evaluate ALL THE POPULAR NATURAL SUPPLEMENT PRODUCTS IN THE MARKET KNOWN TO BE IMMUNE BOOSTERS. The study published in peer review journal in late 1990s evaluated how much a product will (or will not) improve NK cell activity. The study was led by a medical associate professor Darrly See (his CC here) who was with the University of California, Irivine. The studies were confirmed by Russian Scientists from the Russian Academy of Medical Sciences.
STUDIES ON IMMUNE BOOSTING HERBS, PHYTO NUTRIENTS, OTHER BIOTECH PRODUCTS
A total of 196 natural supplements & herbs were tested and compared - such as Noni, aloe, cordyceps, ginseng, shitake mushroom, mitake mushrooms, shark cartilege, astralagus, blue cohosh, bovine colostrum, buckthorn, burdock, chaparral, dandelion, echinacea, garlic, gotu kola, milk thistle, pau d'arco, periwinkle, pycnogenol, quercetin, vitamin C, etc were tested. In addition, chinese herbs - alone and in combinations were tested.
ONE SUBSTANCE STOOD OUT: TRANSFER FACTOR
The best performer was Transfer Factor, and Transfer Factor Plus. The latter out-performed the next best product by 500%. Subsequent research on cancer shows very promising results. (See Research materials here, and what Medical professionals say here ).
See Transfer factor Research on viruses such as:
Herpes | Epstein-Barr | Hepatitis | AIDS | Other viruses
 |
| The research shows that Transfer factor out-perform all other drug, herb, or nutritional substance in medical literature in raising NK cell activity. In this study, the test was carried out on live Leukemia Cancer cells. |
The research shows that Transfer factor out-perform all other drug, herb, or nutritional substance in medical literature in raising NK cell activity. In this study, the test was carried out on live Leukemia Cancer cells.
WHY WOULD A PERSON'S IMMUNE SYSTEM BE WEAKENED? OR PERFORM POORLY?
There are various factors- mainly due to stress, being chronically sick (constant illness), lack of exercise, lacking nutritious food, depression/ poor mental state are some reasons. Other reasons include high consumption of sugar and environmental pollution. The weakened NK cell activity would benefit from Transfer factor.
FROM LABORATORY TO COMMERCIALISATION
Transfer Factor is not a new science though. Transfer Factor was discovered in 1949 by Dr Sherwood Lawrence of New York University. Early work was carried out with Trasfer factor from blood extracts, and with injections. It has over 50 years of research, and an estimated US$40 million spent on research, and 3500 clinical studies and papers done.
The exciting news news is that Transfer factor is now available as a commercial product as as a health supplement - in the form of capsules, tablets, and recently (2005) in liquid form. It is safe for even for infants and naturally safe for adults.
WHAT IS THE SOURCE OF TRANSFER FACTOR?
All animals produce tranfer factor, however scientists prefer to work with bovine (cow) colostrum, and with (chicken) egg yolk extract. A healthy cow already produces millions of different transfer factors, but when the cow does come into contact with a pathogen such as a virus, it produces a new transfer factor for that specific virus or pathogen.
Transfer factor is able to pass through the stomach unharmed by digestive enzymes and stomach acids. The calf is then able to easily absorb this immune memory molecule, which gives it immunity to all the same pathogens as the calf's mother. This inherited immunity will protect the baby from the same disease-causing organisms the mother was protected against.
Transfer factor crosses mammalian species lines. When a person absorbs transfer factor from a cow's colostrum and egg yolk, the person develops resistance to the pathogen to which the cow, and the chicken was exposed.
HOW IS TRANSFER FACTOR PRODUCED FOR HUMAN CONSUMPTION?
Due to practical considerations in the manufacturing and processing of transfer factor, bovine colostrum and avian egg are the preferred sources of transfer factor.
Colostrum from healthy cows is filtered and purified to provide a mixture of transfer factor molecules. Numerous rigorous techniques including further purification and isolation result in pure transfer factor. Every lot produced undergoes rigorous testing, to ensure that the appropriate and effective levels of each transfer factor are present, before it is encapsulated and bottled.
Also, people who are lactose intolerant or who have allergies need not be concerned about a reaction since all traces of milk proteins and lactose are removed during the extraction and concentration process.
USING TRANSFER FACTOR
Transfer factor will not remove or 'cure' the problem in itself; rather transfer factor works to assist and support normal immune system functioning. At the onset individuals typically begin with a high dose and then eventually taper down to a minimum maintenance dose.
BUY NOW
To buy products online click below:
| USA, Australia, New Zealand, Philippines, Taiwan, Korea, UK |
Other countries (Asia- Malaysia, Singapore/ Europe/ Africa) |
| Click here to order online |
|
Herpes |
Epstein-Barr |
Hepatitis
| AIDS
| Other viruses
REVIEW OF SOME MEDICAL LITERATURE
(From Transfer Factor - Natural Immune Booster by William J Hennen, Ph.D)
Herpes
Transfer Factors can help to protect us against viral infections like various strains of herpes and influenza. Chinese and European studies have found a dramatic drop on the duration and recurrence of herpes infections. In a group of thirty-seven patients 62% showed marked improvement by either a decrease of the frequency of recurrence and/or a shortening of duration. To put this in perspective, this group was suffering an average of 12 herpes relapses per year. After herpes-specific Transfer Factor therapy, the number of relapses decreased to 3.5 per year. Even the group of the mist resistant cases had a 50% success rate. (98)
In another study, 22 patients suffering from labial herpes were orally treated with bovine Transfer Factor. Their symptom free time increased from 49 days before treatment to 140 days after treatment (99) All of this data is fully consistent with earlier herpes-specific Transfer Factor reports and further underscores the effectiveness of bovine derived Transfer Factor in treating human disease (21)
Ocular herpes: also responded to Transfer Factor treatment. After Transfer Factor therapy, 134 patient with various ocular herpes infections had only one-third of the number of recurrences as they did prior to therapy. (100). A Chinese clinical study of Transfer Factor on relapsing corneal infection reported an effective rate of 100 percent and the cure rate was 86.6 % (101). A European study showed similar results with a 40-fold drop n recurrence rate and only 18% of the patients suffering any relapse of corneal inflammation during the course of observation (102). Such results are even more amazing when one considers the conventional difficulty in effectively treating herpes, regardless of localization.
Epstein-Barr Virus and Cytomegalovirus
A pilot study used polyvalent Transfer Factor with known potency for Epstein-Barr and cytomegalovirus. In this study two patients demonstrated total remission, 7 showed marked improvement, and 5 displayed no significant response. Initially a non-specific Transfer Factor was used as the control, but even in this case, 3 of 6 patients demonstrated marked improvement. A placebo under the same protocol yielded no clinical improvement. (106)
Hepatitis
The use of Transfer Factor has been shown to be highly effective and not to result in any cases of viral disease or flare up of existing disease. (22). In a study of hepatitis-specific Transfer Factor derived from bovine sources, 52 cases of chronic, persistent, active hepatitis with some cirrhosis after hepatitis were examined. Symptoms improved or disappeared in all patients. It should be noted that the authors made special note that colds and fatigue were especially diminished. Immunological profiles also returned toward normal. (107) In the case of pacental-derived Transfer Factor, 260 cases of hepatitis B were tested and a 100% clinical recovery was reported with no side effects. Immunological profiles were normalized in approximately half of the individuals at the end of the observation period. (22)
Recently 4 patents have been issued to Chinese researchers for preparations of Transfer Factor to treat hepatitis A & B virus infections. (108,109,110,111). It has been reported that 6 million Chinese currently take hepatitis-specific Transfer Factor as a preventive measure.
AIDS
The use of Transfer Factor therapy for AIDS has been hindered by intellectual bias. (20). In spite of this an International Transfer Factor symposium was held which highlighted the recent work of a group of determined scientists. Using Transfer Factor and 80 % inhibition of HIV was demonstrated in vitro. (113). In a combination protocol, HIV-1 specific Transfer Factor with Zidovudine (ZDV) administration orally for 15 days resulted in an increase in white blood cells, CD8 lymphocytes and IL-2 levels, which worked to fight the virus. The combination of ZDV and Transfer Factor appeared to be both safe and well tolerated. (114). The benefits of a combination therapy of antiviral treatments and daily Transfer Factor administration were further demonstrated by a restoration of delayed type hypersensitivity within 60 days. (115).
It is becoming increasingly clear that resistance to HIV infection and to disease progression is unequivocally associated with the cellular mediated immune response. (116). This is the very area where Transfer Factor is effective. (20)
Other viruses
Other viral caused conditions that have been beneficially treated by Transfer Factor preparations include the chicken pox virus, (22) measles virus, (118) and even the common cold. In the case of relief from the common cold this effect was observed as a side effect in the treatment of other conditions. (109,119). |
*
|
SUMMARY
The various newspapers and postings have mentioned about masks, gloves, and gowns, and washing one's hands etc. with regards to deadly Viruses such as SARS. These are all valid. This Q&A serves to share further on the health supplement you can take to help your body defend itself from infection.
LINKS to other sites
Facts about previous flu pandemics, and key facts about bird flu and the avian
influenza A (H5N1) virus.
WHO on Avian influenza
What everyone should know about SARS
Transfer Factor- Business Opportunity - Introduction
DISCLAIMER
Transfer Factor products mentioned here are not designed to prevent, diagnose, cure, or mitigate any diseases, ailments or illnesses. Transfer factors support and modulate the body's immune system. It helps the body to protect, defend, heal itself. If you are ill, we strongly suggest that you consult a medical doctor.
REFERENCES
20. AIDS and Transfer factor: myths, certainties and realities. Viza D. Biotherapy 1996, 9(1-3), 17-26.
21. A canine distemper virus epidemic in Serengeti lions (Pantera leo). Roelke-Parker ME, Muson L, Packer C, Kock R, Cleaveland S, Carpenter M, et. Al. Nature 1996, 379, 441-5.
22. Transfer factor 1993: New Frontiers. Fudenberg HH, Pizza G. Progress in Drug Res. 1994 42, 309-400.
98. Effect of anti-herpes specific Transfer factor. Bryston J, Cech K, Pekarek J, Jilkova J, Biotherapy 1996, 91(1-3), 73-5.
99. Orally administered HSV-specific Transfer factor prevents genital or labial herpes relapes. Pizza G, Viza D, De Vinci C, Palareti A, Cuzzocrea D, Fornarola V, Baricordi R. Bioterapy 1996, 9(1-3), 67-72.
100. Efficacy of Transfer factor in treating patients with recurring ocular herpes infections. Meduri R, Campos E, Scorolli L, De Vinci C, Pizza G, Viza, D. Biotherapy 1996, 9(1-3), 61-6.
101. Clinical study of HSV-specific Transfer factor on relapse HSVK. Anon, Xi’an Yike Daxue Xuebao 1996, 17(3), 322-324.
102. Transfer factor prevents relapses in Herpes keratitis patients: a pilot study. Pizza G, Meduri R, De Vinci C, Scorolli L, Viza D. Biotherapy 1994, 8(1), 63-8.
106. Clinical, epidemilogic and virologic studies in four cluster of the chronic fatique syndrome. Levine PH, Jacobsen S, Pocinki AG, Cheny P, Peterson D
|
